Hybrid adsorption and biological treatment for stormwater using low-cost adsorptive media such as biochar integrated into bioretention. The approach decouples pollutant and hydraulic residence times to capture nitrogen during storm infiltration and support microbial regeneration during dry periods, targeting removal of total nitrogen, ammonia, and pathogens for improved urban water quality.
A stormwater treatment approach that enhances bioretention systems by integrating low-cost adsorptive media, such as biochar, into the bioretention media. The core concept decouples pollutant residence time from hydraulic residence time, allowing nutrients like nitrogen to be captured during storm infiltration and then biologically processed during antecedent dry periods (ADPs). This hybrid adsorption and biological treatment strategy is designed to remove total nitrogen (TN), ammonia (NH4+), and pathogens from urban stormwater runoff, addressing a major water quality challenge in growing urban areas.
The system relies on the following design principles and features:
Builds on prior bench and pilot studies demonstrating enhanced E. coli and TN removal in biochar-amended bioretention media. The research team has validated biochar as an effective ion exchange material for NH4+ and NO3- and has experience with slow-release electron donors to promote denitrification and variable saturation flow modeling. Future validation will include column studies to confirm adsorption behavior, HYDRUS model validation, and full-scale testing using BioPods fed with stormwater from a campus stormwater pond. The project is positioned between laboratory validation and pilot-scale demonstration, with the goal of advancing toward commercial deployment.
A comprehensive public research university with multiple campuses across the Tampa Bay region, USF combines scale with an applied, partnership‑driven culture. A research and technology park anchors co‑located corporate R&D, startups, and shared facilities that enable prototyping and testing. USF Health’s connection to a major hospital system and nearby specialty clinics supports clinical studies, device validation, and translational collaborations. Research is supported by competitive federal funding from agencies such as NIH, NSF, and DoD. A dedicated technology transfer office and research foundation manage IP, licensing, industry agreements, and venture creation, with incubator and accelerator resources in the park.